Advertisement
Contempo Updates
Linking Evidence and Experience
JAMA. 2003;289(19):2475-2479. doi: 10.1001/jama.289.19.2475

Assessment and Management of Insomnia

  1. Carlos H. Schenck, MD;
  2. Mark W. Mahowald, MD;
  3. Robert L. Sack, MD
  1. Author Affiliations: Departments of Psychiatry (Dr Schenck) and Neurology (Dr Mahowald), Minnesota Regional Sleep Disorders Center, Hennepin County Medical Center and University of Minnesota Medical School, Minneapolis; and Department of Psychiatry, Oregon Health Sciences University, Portland (Dr Sack).

Since this article does not have an abstract, we have provided the first 150 words of the full text.

Insomnia is a common treatable disorder of insufficient or poor-quality sleep, with adverse daytime consequences.1 Insomnia presents as trouble falling asleep (long-sleep latency), trouble staying asleep (excessive or prolonged awakenings), or feeling nonrestored from sleep. Insomnia can be a primary disorder emerging in childhood or later, a conditioned (psychophysiological) disorder, or comorbid with a psychiatric, medical, or other sleep disorder.1 Insomnia can be transient (related to stress, illness, travel) or chronic (occurring nightly for >6 months). Persistent untreated insomnia is a strong risk factor for major depression.2 Insomnia must be distinguished from sleep-state misperception and short sleep states without symptoms.1

More than 50 epidemiological studies have shown that one third of various general populations have insomnia symptoms and that 9% to 21% have insomnia with serious daytime consequences, such as bodily fatigue, diminished energy, difficulty concentrating, memory impairment, low motivation, loss of productivity, irritability, interpersonal difficulties …

Related article

« Previous | Next Article »Table of Contents

More in JAMA & Archives Journals